At La Jolla Institute for Immunology (LJI), we study the foundations of the immune system so we can combat disease as strategically as possible. We are guiding the development of new therapeutics that are effective, long-lasting, and personalized to work best for each person.
At La Jolla Institute for Immunology (LJI), we study the foundations of the immune system so we can combat disease as strategically as possible. We are guiding the development of new therapeutics that are effective, long-lasting, and personalized to work best for each person.
Our research, and the tools we have developed, have launched strategic national resources that fuel discovery across the United States. LJI scientists have developed the Immune Epitope Database (IEDB), which allows us to move quickly to address autoimmune diseases and emerging infectious diseases. We also run the Cancer Epitope Database and Analysis Resource (CEDAR) to study how immune cells target cancer, and the Database of Immune Cell Epigenomes (DICE) to investigate how genes control the immune system. Researchers across the nation use these resources to pursue new cancer immunotherapies and lifesaving vaccines.
We’ve also strengthened biomedical research by leading other scientists in national efforts. LJI scientists recently partnered with the international Immunological Genome Project (ImmGen) consortium to develop a new “spatial transcriptomics” resource to track immune-cell activities in different organs. My own lab leads America’s SHIELD, a national consortium of scientists working to develop lifesaving vaccines against viral causes of cancer and birth defects.
LJI supporters are leaders in our shared mission to fight disease and ensure humanity can benefit from cutting-edge medical advances. Funding from ARPA-H, the National Institutes of Health, the Department of Defense, and other government agencies empowers our scientists to take on the most pressing problems in human health. Federal sources provide 70 percent of our fuel for existing projects and our current scientists and staff.
Philanthropic funding is essential for the rest, and for anything new: new directions, new ideas, new hires to take us down new paths. Your gifts are critical in moving new therapies forward, and the best part of our work together is helping those discoveries unfold and enjoying the rippling positive impact.
Your support means everything to us.
Sincerely,
Erica Ollmann Saphire, Ph.D., MBA
Professor, President & CEO
La Jolla Institute for Immunology
